BioSpectrum Asia - 2022-04-15

• RUSSO-UKRAINE DOMINO EFFECT
• China approves first thermal vapour energy system
• Japan gives nod to Guardant Health’s liquid biopsy test
• Australia invests $28.1M to establish new genomics agency
• Singapore recommends second booster dose of mRNA vaccine for 80+
• DCGI grants EUA for Novavax’ COVID-19 vaccine for adolescent­s
• Australia, South Korea sign MoU on vaccine research
• World’s first lung scanner becomes available for Australian­s
• Astellas’ menopause drug fails in Asia trial
• Pfizer’s oral COVID-19 drug to hit shelves in 95 countries
• Bharat Biotech, Biofabri to develop and distribute novel TB vaccine
• IGene Lab introduces saliva-based COVID-19 PCR tests in Singapore
• Taiwan firms to develop global CDMO for inhalation treatment drugs
• Huadong Medicine becomes strategic partner for Heidelberg Pharma in Asia
• RedHill inks $6M deal with Kukbo for COVID-19 drug in South Korea
• India’s Trivitron Healthcare acquires The Kennedy Company, USA
• Triastek, Siemens to jointly address pharma needs and improve patient outcomes
• Singapore’s NDR Medical expands APAC presence
• Singleron acquires Proteona and extends reach outside China
• Servatus commission­s clinical trial of live biotherape­utics on insomnia patients
• CoreTissue BioEnginee­ring to be first Japanese startup at JPOD @ Boston
• Mylab opens new facility for advanced diagnostic­s in India
• UNICEF to procure 4M treatment courses of Pfizer’s PAXLOVID
• Firms form CGTA to raise awareness on CardioGeno­mic Testing
• NIH launches biomarker testing for CNS tumours in children
• Moderna to commence mRNA shots production in Kenya
• Peru, Brazil to mutually strengthen and improve health services
• EU commits €24.5M for WHO’s healthcare initiate in Africa
• WHO issues guidelines to ‘pandemic influenza’
• WHO enhances lab biosafety in South East Asia
• Investment towards TB services & research must be increased: WHO
• WHY HOLOMEDICI­NE IS RAPIDLY GAINING GROUND
• Global associatio­n for Holomedici­ne
• LATEST DEVELOPMEN­TS
• BIG PHARMA’S 3D PRINTING
• APPROVED RNA THERAPEUTI­CS
• China’s Zai Labs appoints Josh Smiley as COO
• Takeda Pharmaceut­ical appoints Serina Fischer as GM for India
• Royal Society of Edinburgh elects Kiran Mazumdar-Shaw as Fellow
• Aussie Institute combines statins with Evolocumab to lower heart attacks
• Korea develops mindreadin­g system for decoding brain signals
• New Zealand to develop mRNA vaccine for Staph bug
• India opens research centre for Duchenne Muscular Dystrophy treatment
• Thailand unveils urine HPV paperbased DNA sensor testing kits for cervical cancer
• NTU Singapore patents ‘direct to cell’ drug delivery platform
• IISc, Bengaluru to set up Isaac Centre for Public Health
• New Aussie National Academic Centre to help ensure healthy ageing
• Peking University launches PKU Medicine 2022 Overseas Excellent Youth Project
• Agilent opens 4th Centre for Excellence in India
• Waters introduces automated solution for mass and purity analysis of biomolecul­es
• Thermo Fisher introduces new large-volume electropor­ation system
• Shimadzu releases new IRXross Fourier Transform Infrared Spectropho­tometer
• MilliporeS­igma acquires Exelead and to invest €500M to scale-up technology
• Eppendorf invests in Swiss startup BigOmics

BioSpectrum Asia - 2022-03-15

BioSpectrum Asia - 2022-05-15